PT2988782T - Formas de dosagem para administração oral de substâncias ativas - Google Patents
Formas de dosagem para administração oral de substâncias ativasInfo
- Publication number
- PT2988782T PT2988782T PT14731011T PT14731011T PT2988782T PT 2988782 T PT2988782 T PT 2988782T PT 14731011 T PT14731011 T PT 14731011T PT 14731011 T PT14731011 T PT 14731011T PT 2988782 T PT2988782 T PT 2988782T
- Authority
- PT
- Portugal
- Prior art keywords
- dosage forms
- oral administration
- active substances
- substances
- active
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title 1
- 239000002552 dosage form Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000682A ITMI20130682A1 (it) | 2013-04-24 | 2013-04-24 | Forme di dosaggio per la somministrazione orale di sostanze attive |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2988782T true PT2988782T (pt) | 2019-09-10 |
Family
ID=48748359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT14731011T PT2988782T (pt) | 2013-04-24 | 2014-04-22 | Formas de dosagem para administração oral de substâncias ativas |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20160081935A1 (pt) |
| EP (1) | EP2988782B1 (pt) |
| CA (1) | CA2910354C (pt) |
| CY (1) | CY1122160T1 (pt) |
| DK (1) | DK2988782T3 (pt) |
| ES (1) | ES2741501T3 (pt) |
| HR (1) | HRP20191493T1 (pt) |
| HU (1) | HUE044668T2 (pt) |
| IT (1) | ITMI20130682A1 (pt) |
| LT (1) | LT2988782T (pt) |
| PL (1) | PL2988782T3 (pt) |
| PT (1) | PT2988782T (pt) |
| RS (1) | RS59133B1 (pt) |
| SI (1) | SI2988782T1 (pt) |
| TR (1) | TR201910708T4 (pt) |
| WO (1) | WO2014174430A1 (pt) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6319510B1 (en) * | 1999-04-20 | 2001-11-20 | Alayne Yates | Gum pad for delivery of medication to mucosal tissues |
| WO2002064148A2 (en) * | 2001-02-16 | 2002-08-22 | Shimizu Pharmaceutical Co., Ltd. | Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders |
| US20020172712A1 (en) * | 2001-03-19 | 2002-11-21 | Alan Drizen | Antiemetic, anti-motion sustained release drug delivery system |
| US7767806B2 (en) * | 2003-09-08 | 2010-08-03 | Chugai Seiyaku Kabushiki Kaisha | Hyaluronic acid modification products and drug carriers using them |
| WO2005105036A1 (en) * | 2004-04-28 | 2005-11-10 | Natco Pharma Limited | Controlled release mucoadhesive matrix formulation containing tolterodine and a process for its preparation |
| ITMI20050262A1 (it) * | 2005-02-21 | 2006-08-22 | Carlo Ghisalberti | Sostanze composizioni e metodi di trattamento dell'alopecia |
| US20100098794A1 (en) * | 2008-10-17 | 2010-04-22 | Armand Gerard | Topical anti-wrinkle and anti-aging moisturizing cream |
-
2013
- 2013-04-24 IT IT000682A patent/ITMI20130682A1/it unknown
-
2014
- 2014-04-22 PT PT14731011T patent/PT2988782T/pt unknown
- 2014-04-22 HU HUE14731011 patent/HUE044668T2/hu unknown
- 2014-04-22 EP EP14731011.4A patent/EP2988782B1/en active Active
- 2014-04-22 PL PL14731011T patent/PL2988782T3/pl unknown
- 2014-04-22 LT LTEP14731011.4T patent/LT2988782T/lt unknown
- 2014-04-22 ES ES14731011T patent/ES2741501T3/es active Active
- 2014-04-22 WO PCT/IB2014/060892 patent/WO2014174430A1/en active Application Filing
- 2014-04-22 TR TR2019/10708T patent/TR201910708T4/tr unknown
- 2014-04-22 US US14/786,496 patent/US20160081935A1/en not_active Abandoned
- 2014-04-22 SI SI201431283T patent/SI2988782T1/sl unknown
- 2014-04-22 CA CA2910354A patent/CA2910354C/en active Active
- 2014-04-22 DK DK14731011.4T patent/DK2988782T3/da active
- 2014-04-22 RS RS20191015A patent/RS59133B1/sr unknown
-
2019
- 2019-08-19 HR HRP20191493 patent/HRP20191493T1/hr unknown
- 2019-08-22 CY CY20191100901T patent/CY1122160T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK2988782T3 (da) | 2019-07-29 |
| ES2741501T3 (es) | 2020-02-11 |
| RS59133B1 (sr) | 2019-09-30 |
| CA2910354C (en) | 2021-04-27 |
| SI2988782T1 (sl) | 2019-09-30 |
| CY1122160T1 (el) | 2020-11-25 |
| TR201910708T4 (tr) | 2019-08-21 |
| CA2910354A1 (en) | 2014-10-30 |
| ITMI20130682A1 (it) | 2014-10-25 |
| PL2988782T3 (pl) | 2019-12-31 |
| HRP20191493T1 (hr) | 2019-11-15 |
| EP2988782A1 (en) | 2016-03-02 |
| HUE044668T2 (hu) | 2019-11-28 |
| LT2988782T (lt) | 2019-08-12 |
| US20160081935A1 (en) | 2016-03-24 |
| EP2988782B1 (en) | 2019-05-22 |
| WO2014174430A1 (en) | 2014-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2968071T3 (pl) | Urządzenie do doustnego dostarczania związków leczniczych | |
| HK1223935A1 (zh) | 無定形萊特莫韋及其用於口服施用的固體藥物製劑 | |
| HK1217443A1 (zh) | 用於糖尿病的口服治療的藥物組合物 | |
| EP3038465A4 (en) | Oral pharmaceutical formulation of omarigliptin | |
| HK1221152A1 (zh) | 用於呋塞米的皮下施用的藥物製劑 | |
| AP3803A (en) | Pharmaceutical dosage form | |
| HK1223833A1 (zh) | 藥物劑型 | |
| DK2964193T3 (da) | Lægemidler til oral indgivelse | |
| EP2968179A4 (en) | RETARD-PRESENTATIONS | |
| EP2958593A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TRANSMUCOSAL ADMINISTRATION OF BENZODIAZEPINES | |
| GB201305103D0 (en) | An oral dosage form | |
| EP2979698A4 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
| RS59133B1 (sr) | Oblici doze za oralnu primenu aktivnih supstanci | |
| IL240119A0 (en) | Pharmaceutical compositions for oral treatment of diabetes | |
| ZA201502354B (en) | Pharmaceutical dosage form | |
| ITMI20120350A1 (it) | Forma di dosaggio per somministrazione orale di principi attivi |